Cellarity, a biotechnology company developing cell state-correcting therapies through integrated multi-omics and AI modeling, ...
This study offers a valuable methodological advance by introducing a gene panel selection approach that captures combinatorial specificity to define cell identity. The findings address key limitations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback